Most opponents of the pharmaceutical industry's structure want the FDA, NIH, or government to run industrial policy by choosing which drug pathways to pursue, and that approach always loses to decentralized information because bureaucracy is sluggish.
normativepending
Speaker
Richard EpsteinEvidence Quote
“Decentralized information will trump centralized control with all of its bureaucratic sluggishness every time out of the box.”
Created: 10/30/2026, 3:22:16 PM
Your notes
Loading notes...